gut.bmj1d
Cautious view on the link between yoghurt consumption and risk of colorectal cancer
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj1d
REVIEW OF HOSPITAL PATIENTS WITH ALT>1000 IU/L
Introduction There are many potential causes for an ALT>1000 IU/L, the commonest being ischaemia, drug induced liver injury (DILI) and viral hepatitis. There are however many other potential causes, ...
gut.bmj2d
Acute toxic gastric mucosal damage induced by Lugol’s iodine spray during chromoendoscopy
1 Department of Gastroenterology, The General Infirmary at Leeds, Leeds, UK 2 Department of Histopathology, The General Infirmary at Leeds, Leeds, UK 3 Department of Gastroenterology, The General ...
gut.bmj3d
PMO-5 Steroids and tapering regimes in Inflammatory Bowel Disease – What do we prescribe?
Introduction Steroids have been an established treatment in flares of inflammatory bowel disease (IBD) for the past 50 years. Whilst evidence exists to guide the initial dose of these drugs, data ...
gut.bmj3d
Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology
24 Gastroenterology and Liver Unit, Royal Hallamshire Hospital & University of Sheffield, Sheffield, UK Correspondence to David S Sanders, Gastroenterology and Liver Unit, Royal Hallamshire Hospital & ...
gut.bmj4d
PMO-076 Assessment of the probiotic symprove in patients with IBS: a randomised double blind placebo controlled trial
2 Department of Primary Care and Public Health Sciences, King's College London, London, UK Methods Material and Methods: This was a single centre, double blind, randomised, placebo controlled trial ...
gut.bmj5d
Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium
Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany Correspondence to Dr Christoph Becker, 1. Department of Medicine, University of Erlangen-Nuremberg, Hartmannstrasse 14, 91 ...
gut.bmj5d
Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease
Professor J P Galmiche, Centre de Recherche en Nutrition Humaine, CRI INSERM 95-08, CHU, Hôtel Dieu, Place A Ricordeau, 44035 Nantes cedex 01, France. Email:galmiche{at}easynet.fr BACKGROUND/AIM ...
gut.bmj6d
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
1 Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA 2 Division of Biostatistics, Mayo Clinic and Foundation, Rochester, MN, USA Correspondence to: Dr E V ...
gut.bmj7d
Screening of normal endoscopic large bowel biopsies with interpretable graph learning: a retrospective study
Objective To develop an interpretable artificial intelligence algorithm to rule out normal large bowel endoscopic biopsies, saving pathologist resources and helping with early diagnosis. Design A ...
gut.bmj7d
Tight junction proteins in gastrointestinal and liver disease
Over the past two decades a growing body of evidence has demonstrated an important role of tight junction (TJ) proteins in the physiology and disease biology of GI and liver disease. On one side, TJ ...
gut.bmj8d
A novel prognostic model for transplant-free survival in primary sclerosing cholangitis
Objective Most prognostic models for primary sclerosing cholangitis (PSC) are based on patients referred to tertiary care and may not be applicable for the majority of patients with PSC. The aim of ...